28 April 2023
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group)
Holdings in Company
Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free ElectrolyserTM, was notified on 26 April 2023 that Aurelius Limited now holds 20,448,881 ordinary shares in the Company, representing approximately 7.62% of the issued share capital of the Company. The Aurelius Limited shareholder was previously disclosed as the Manny Davidson Discretionary Trust.
For more information, please contact:
Clean Power Hydrogen plc | via Camarco |
Jon Duffy, Chief Executive Officer James Hobson, Chief Financial Officer | |
| |
Cenkos Securities plc - NOMAD & Broker | |
Neil McDonald | +44 (0)131 220 9771 |
Peter Lynch | +44 (0)131 220 9772 |
Adam Rae | +44 (0)131 220 9778 |
| |
Camarco PR | + 44(0) 203 757 4980 |
Billy Clegg | |
Owen Roberts | |
Lily Pettifar | |
Notes to Editors
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("CleanPower") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.
The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.